NeoImmune NMTNT110

Clinical Trial Grant

Duke Scholars

Principal Investigator Christopher Hoimes Medicine, Medical Oncology

Awarded By

NeoImmuneTech, Inc.

Start Date

August 7, 2020

End Date

July 30, 2025

Awarded By

NeoImmuneTech, Inc.

Start Date

August 7, 2020

End Date

July 30, 2025